Datavault AI Awards $10M Exclusive License to Scilex for Biotech Asset Tokenization

Reuters

2025/11/05

Datavault AI Awards $10M Exclusive License to Scilex for Biotech Asset Tokenization

Datavault AI Inc. has announced the signing of a $10 million worldwide exclusive license agreement with Scilex Holding Company for the tokenization and monetization of real-world assets in the biotech and biopharma sector. Under the agreement, Datavault AI will receive a nonrefundable upfront license fee in four equal installments of $2.5 million, payable by Scilex on or before December 31, 2025, March 31, 2026, June 30, 2026, and September 30, 2026. In addition, Datavault AI is eligible to receive up to $2.55 billion in sales milestone payments upon Scilex achieving certain sales targets. The agreement grants Scilex the right to use Datavault AI's proprietary technology for creating and operating a Biotech Exchange platform focused on secure tokenization, trading, and monetization of biotech assets, including genomic and DNA data, diagnostics, therapeutics, genetic information, and drug data.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Datavault Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9568504-en) on November 04, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2581771754"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581771754\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581771754?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 01:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581771754","market":"us","top_or_hot":-1,"title":"Datavault AI Awards $10M Exclusive License to Scilex for Biotech Asset Tokenization","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Datavault AI Awards $10M Exclusive License to Scilex for Biotech Asset Tokenization\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/DVLT\">Datavault AI Inc.</a> has announced the signing of a $10 million worldwide exclusive license agreement with <a href=\"https://laohu8.com/S/SCLX\">Scilex Holding Company</a> for the tokenization and monetization of real-world assets in the biotech and biopharma sector. Under the agreement, Datavault AI will receive a nonrefundable upfront license fee in four equal installments of $2.5 million, payable by Scilex on or before December 31, 2025, March 31, 2026, June 30, 2026, and September 30, 2026. In addition, Datavault AI is eligible to receive up to $2.55 billion in sales milestone payments upon Scilex achieving certain sales targets. The agreement grants Scilex the right to use Datavault AI's proprietary technology for creating and operating a Biotech Exchange platform focused on secure tokenization, trading, and monetization of biotech assets, including genomic and DNA data, diagnostics, therapeutics, genetic information, and drug data.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Datavault Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9568504-en) on November 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Datavault AI Awards $10M Exclusive License to Scilex for Biotech Asset Tokenization</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDatavault AI Awards $10M Exclusive License to Scilex for Biotech Asset Tokenization\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-05 01:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Datavault AI Awards $10M Exclusive License to Scilex for Biotech Asset Tokenization\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/DVLT\">Datavault AI Inc.</a> has announced the signing of a $10 million worldwide exclusive license agreement with <a href=\"https://laohu8.com/S/SCLX\">Scilex Holding Company</a> for the tokenization and monetization of real-world assets in the biotech and biopharma sector. Under the agreement, Datavault AI will receive a nonrefundable upfront license fee in four equal installments of $2.5 million, payable by Scilex on or before December 31, 2025, March 31, 2026, June 30, 2026, and September 30, 2026. In addition, Datavault AI is eligible to receive up to $2.55 billion in sales milestone payments upon Scilex achieving certain sales targets. The agreement grants Scilex the right to use Datavault AI's proprietary technology for creating and operating a Biotech Exchange platform focused on secure tokenization, trading, and monetization of biotech assets, including genomic and DNA data, diagnostics, therapeutics, genetic information, and drug data.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Datavault Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9568504-en) on November 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B3QW5Z07.USD","symbol_name":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL4ggFnV:1","article_id":"2581771754","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581771754","pubTimestamp":1762276678,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Datavault AI Inc. has announced the signing of a $10 million worldwide exclusive license agreement with Scilex Holding Company for the tokenization and monetization of real-world assets in the biotech and biopharma sector. Under the agreement, Datavault AI will receive a nonrefundable upfront license fee in four equal installments of $2.5 million, payable by Scilex on or before December 31, 2025, March 31, 2026, June 30, 2026, and September 30, 2026. In addition, Datavault AI is eligible to receive up to $2.55 billion in sales milestone payments upon Scilex achieving certain sales targets. The agreement grants Scilex the right to use Datavault AI's proprietary technology for creating and operating a Biotech Exchange platform focused on secure tokenization, trading, and monetization of biotech assets, including genomic and DNA data, diagnostics, therapeutics, genetic information, and drug data.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4588":"碎股","NDAQ":"纳斯达克OMX交易所","SCLX":"Scilex Holding Company","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4585":"ETF&股票定投概念","BK4112":"金融交易所和数据","BK4141":"半导体产品","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","DVLT":"Datavault AI Inc.","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","BK4007":"制药","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD"},"translate_title":"Datavault AI向Scilex授予价值1000万美元的生物技术资产代币化独家许可","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SCLX":0.9,"DVLT":0.9,"NDAQ":0.9},"content_text":"Datavault AI Awards $10M Exclusive License to Scilex for Biotech Asset Tokenization\n    \n\nDatavault AI Inc. has announced the signing of a $10 million worldwide exclusive license agreement with Scilex Holding Company for the tokenization and monetization of real-world assets in the biotech and biopharma sector. Under the agreement, Datavault AI will receive a nonrefundable upfront license fee in four equal installments of $2.5 million, payable by Scilex on or before December 31, 2025, March 31, 2026, June 30, 2026, and September 30, 2026. In addition, Datavault AI is eligible to receive up to $2.55 billion in sales milestone payments upon Scilex achieving certain sales targets. The agreement grants Scilex the right to use Datavault AI's proprietary technology for creating and operating a Biotech Exchange platform focused on secure tokenization, trading, and monetization of biotech assets, including genomic and DNA data, diagnostics, therapeutics, genetic information, and drug data.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Datavault Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9568504-en) on November 04, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}